Pamela Vig - 10 Nov 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Head of Research & Development
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2022
Net transactions value
+$11,254
Form type
4
Filing time
14 Nov 2022, 20:43:38 UTC
Previous filing
12 May 2022
Next filing
18 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $11,254 +660 +3.1% $17.05 21,902 10 Nov 2022 Direct F1
holding MIRM Common Stock 75,000 10 Nov 2022 By The Vig-Ancock Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 660 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.